[Antitumor Study of Neoantigen-reactive T Cells Co-expressing IL-7 and CCL19 in Mouse Lung Cancer].
Di WuChenhui LiYan WangZhengqiang HeChang'e JinMin GuoRongchang ChenChengzhi Zhou
Published in: Zhongguo fei ai za zhi = Chinese journal of lung cancer (2024)
The anti-solid tumor ability of NRT cells is significantly enhanced by the arming of IL-7 and CCL19, which is a safe and effective genetic modification of NRT.